HIT Consultant August 22, 2024
Fred Pennic

What You Should Know:

Openwater, a pioneering healthcare technology company, today announced the acceleration of its plans to commercialize its groundbreaking platform that leverages semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level.

– Founded by Mary Lou Jepsen, a former executive at Google X, Meta, and “One Laptop Per Child,” Openwater has secured $100M in funding to advance its mission of making advanced medical care accessible worldwide. The investment round was backed by prominent investors including Plum Alley Ventures, Khosla Ventures, BOLD Capital Partners, Esther Dyson, and Peter Gabriel.

Fighting Disease with Technology

Openwater’s innovative platform combines high-resolution infrared imaging, precision-tuned ultrasound, and targeted electromagnetic fields to enable unprecedented visualization, monitoring, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article